Literature DB >> 11418630

Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation.

M J Parsons1, R G Jones, M S Tsao, B Odermatt, P S Ohashi, J R Woodgett.   

Abstract

The molecular mechanisms that contribute to autoimmunity remain poorly defined. While inflammation is considered to be one of the major checkpoints in autoimmune disease progression, very little is known about the initiating events that trigger inflammation. We have studied transgenic mice expressing the prosurvival molecule protein kinase B/Akt under control of a T cell-specific CD2 promoter. In this study, we demonstrate that aged mice develop lymphadenopathy and splenomegaly that result from an accumulation of CD4, CD8, and unexpectedly B cells. An increased proportion of T cells express activation markers, while T cell proliferative responses remain normal. B cells are hyperproliferative in response to anti-IgM F(ab')(2) and anti-CD40, and increased IgA and IgG2a were found in the sera. In addition, a profound multiorgan lymphocytic infiltration is observed, and T cells from these mice display a defect in Fas-mediated apoptosis, which may be the mechanism underlying this phenotype. Therefore, T cell expression of active protein kinase B can alter T cell homeostasis, indirectly influence B cell homeostasis, and promote inflammation in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418630     DOI: 10.4049/jimmunol.167.1.42

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  T-cell antigen receptor signal transduction.

Authors:  Doreen A Cantrell
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

2.  Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells.

Authors:  J L Moody; F R Jirik
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

3.  Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.

Authors:  Steven J Bensinger; Patrick T Walsh; Jidong Zhang; Martin Carroll; Ramon Parsons; Jeffrey C Rathmell; Craig B Thompson; Matthew A Burchill; Michael A Farrar; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

4.  Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus.

Authors:  S Malstrom; E Tili; D Kappes; J D Ceci; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 5.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

6.  IL-10 and ICOS Differentially Regulate T Cell Responses in the Brain during Chronic Toxoplasma gondii Infection.

Authors:  Carleigh A O'Brien; Samantha J Batista; Katherine M Still; Tajie H Harris
Journal:  J Immunol       Date:  2019-02-04       Impact factor: 5.422

7.  T cell PKCδ kinase inactivation induces lupus-like autoimmunity in mice.

Authors:  Gabriela Gorelik; Amr H Sawalha; Dipak Patel; Kent Johnson; Bruce Richardson
Journal:  Clin Immunol       Date:  2015-03-28       Impact factor: 3.969

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

9.  Protein kinase N1, a cell inhibitor of Akt kinase, has a central role in quality control of germinal center formation.

Authors:  Teruhito Yasui; Kaori Sakakibara-Yada; Taki Nishimura; Kentaro Morita; Satoru Tada; George Mosialos; Elliott Kieff; Hitoshi Kikutani
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

Review 10.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.